New Blood Test is More Accurate in Identifying Osteoarthritis Progression
A new blood test that can identify progression of osteoarthritis in the knee is more accurate than current methods.
A new blood test that can identify progression of osteoarthritis in the knee is more accurate than current methods.
AMSBIO has expanded its iMatrix series of recombinant laminin E8 fragments to now include laminin isoforms LN-111 and LN-332.
Researchers have developed a microscopy system for non-invasive conjunctival goblet cells examination in patients.
Results from the IMPACT trial demonstrate clear patient benefit in using Roche’s CINtec PLUS Cytology dual-stain biomarker technology.
StatLab provides products and support directly to anatomic pathology and will now partner with Thomas Scientific to distribute its solutions.
ZEISS unveiled two new software functionalities to help medical professionals achieve better results in confocal microscopy.
Akoya Biosciences has announced the commercial availability of the PhenoCycler-Fusion system for high-speed imaging of whole slides.
Increased availability of such devices may help to facilitate continuity of patient care by preventing disruptions to critical pathology services.
FoundationOne CDx is used as a companion diagnostic for two groups of FDA-approved therapeutics in melanoma, which includes BRAF inhibitor monotherapies.
Codex technology combines the advantages of single-cell biology with histology at single-cell spatial resolution.